We are live on ! Find out more
BCDAW

BioCardia, Inc. Warrant
BCDAW

Delisted

BCDAW was delisted on the 2nd of August, 2024.

Back to rankings

5 hedge funds and large institutions have $27K invested in BioCardia, Inc. Warrant in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% less funds holding

Funds holding: 6 → 5 (-1)

86% less capital invested

Capital invested by funds: $199K → $27K (-$172K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
-$175K
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
1
Empery Asset Management
New York
$15K – – –
Osaic Holdings
2
Osaic Holdings
Arizona
$7K – – –
G
3
GenTrust
Florida
$4K – – –
Bank of America
4
Bank of America
North Carolina
$1K – – –
CAPTRUST Financial Advisors
5
CAPTRUST Financial Advisors
North Carolina
– -$175K -500,000 Closed

BCDAW Hedge Fund Activity: Q3 2022 in Review

5 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in BioCardia, Inc. Warrant (BCDAW) for Q3 2022, worth a combined $27K — down 86% from $199K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of BCDAW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was CAPTRUST Financial Advisors, exiting entirely with an estimated $175K sold.

  • 5 institutional investors held BioCardia, Inc. Warrant (BCDAW) as of Q3 2022, down from 6 in Q2 2022.
  • Funds reported $27K of BioCardia, Inc. Warrant stock for Q3 2022, down 86% quarter-over-quarter.
  • 0 funds opened new BioCardia, Inc. Warrant positions in Q3 2022 and 1 closed out, a net change of -1 holder.
  • The largest BioCardia, Inc. Warrant seller in Q3 2022 was CAPTRUST Financial Advisors, an estimated $175K sold.

Based on aggregated 13F filings for Q3 2022.